Dijon, June 13, 2022 at 6:00 p.m. CEST – ONCODESIGN (FR0011766229 – ALONC), a biopharmaceutical group specializing in precision medicine, announces the availability of the preparatory documents for the Combined General Meeting of June 30, 2022.
In addition, the Company informs its shareholders that its General Meeting will be held on Thursday June 30, 2022, at 9:30 a.m. at 20 Rue Jean Mazen in DIJON (and no longer on June 29, 2022 as previously announced).
The documents relating to this general meeting are made available to shareholders and can be consulted on the Oncodesign website in the section Investors / Documentation / General Meetings: https://www.oncodesign.com/fr/documentation/assemblees- generals/general-assembly-2022
It is also possible to consult the documentation at the registered office of the Company at 18 rue Jean Mazen in DIJON – 21000. Each shareholder may also request that a copy of these documents be sent to him.